124 related articles for article (PubMed ID: 21324460)
1. VEGF-A-induced chemotaxis of CD16+ monocytes is decreased secondary to lower VEGFR-1 expression.
Czepluch FS; Olieslagers S; van Hulten R; Vöö SA; Waltenberger J
Atherosclerosis; 2011 Apr; 215(2):331-8. PubMed ID: 21324460
[TBL] [Abstract][Full Text] [Related]
2. Interaction of angiogenically stimulated intermediate CD163+ monocytes/macrophages with soft hydrophobic poly(n-butyl acrylate) networks with elastic moduli matched to that of human arteries.
Mayer A; Kratz K; Hiebl B; Lendlein A; Jung F
Artif Organs; 2012 Mar; 36(3):E28-38. PubMed ID: 22360779
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.
Skrzeczyńska-Moncznik J; Bzowska M; Loseke S; Grage-Griebenow E; Zembala M; Pryjma J
Scand J Immunol; 2008 Feb; 67(2):152-9. PubMed ID: 18201370
[TBL] [Abstract][Full Text] [Related]
4. Diverging biological roles among human monocyte subsets in the context of tuberculosis infection.
Balboa L; Barrios-Payan J; González-Domínguez E; Lastrucci C; Lugo-Villarino G; Mata-Espinoza D; Schierloh P; Kviatcovsky D; Neyrolles O; Maridonneau-Parini I; Sánchez-Torres C; Sasiain Mdel C; Hernández-Pando R
Clin Sci (Lond); 2015 Aug; 129(4):319-30. PubMed ID: 25858460
[TBL] [Abstract][Full Text] [Related]
5. Human monocyte heterogeneity--a nephrological perspective.
Rogacev KS; Heine GH
Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
[TBL] [Abstract][Full Text] [Related]
6. The classical CD14⁺⁺ CD16⁻ monocytes, but not the patrolling CD14⁺ CD16⁺ monocytes, promote Th17 responses to Candida albicans.
Smeekens SP; van de Veerdonk FL; Joosten LA; Jacobs L; Jansen T; Williams DL; van der Meer JW; Kullberg BJ; Netea MG
Eur J Immunol; 2011 Oct; 41(10):2915-24. PubMed ID: 21695694
[TBL] [Abstract][Full Text] [Related]
7. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M
Circ Res; 2003 Mar; 92(4):378-85. PubMed ID: 12600898
[TBL] [Abstract][Full Text] [Related]
8. [CD14++CD16- and CD14+CD16+ human monocytes adhesion to endothelial cells].
Starikova EA; Lebedeva AM; Freĭdlin IS
Tsitologiia; 2010; 52(5):380-3. PubMed ID: 20586272
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
11. Different functions of monocyte subsets in familial hypercholesterolemia: potential function of CD14+ CD16+ monocytes in detoxification of oxidized LDL.
Mosig S; Rennert K; Krause S; Kzhyshkowska J; Neunübel K; Heller R; Funke H
FASEB J; 2009 Mar; 23(3):866-74. PubMed ID: 19001052
[TBL] [Abstract][Full Text] [Related]
12. Monocyte subtypes predict clinical course and prognosis in human stroke.
Urra X; Villamor N; Amaro S; Gómez-Choco M; Obach V; Oleaga L; Planas AM; Chamorro A
J Cereb Blood Flow Metab; 2009 May; 29(5):994-1002. PubMed ID: 19293821
[TBL] [Abstract][Full Text] [Related]
13. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
14. Expansion of CD14+CD16+ monocytes producing TNF-α in complication-free diabetes type 1 juvenile onset patients.
Myśliwska J; Smardzewski M; Marek-Trzonkowska N; Myśliwiec M; Raczyńska K
Cytokine; 2012 Oct; 60(1):309-17. PubMed ID: 22484242
[TBL] [Abstract][Full Text] [Related]
15. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
[TBL] [Abstract][Full Text] [Related]
16. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates.
Grage-Griebenow E; Flad HD; Ernst M; Bzowska M; Skrzeczyñska J; Pryjma J
Immunobiology; 2000 May; 202(1):42-50. PubMed ID: 10879688
[TBL] [Abstract][Full Text] [Related]
17. Chemotaxis analysis of circulating monocytes in patients with a recent acute coronary syndrome.
Czepluch FS; Zweigle B; Waltenberger J
Atherosclerosis; 2009 May; 204(1):304-8. PubMed ID: 18842265
[TBL] [Abstract][Full Text] [Related]
18. Standardized single-platform assay for human monocyte subpopulations: Lower CD14+CD16++ monocytes in females.
Heimbeck I; Hofer TP; Eder C; Wright AK; Frankenberger M; Marei A; Boghdadi G; Scherberich J; Ziegler-Heitbrock L
Cytometry A; 2010 Sep; 77(9):823-30. PubMed ID: 20662093
[TBL] [Abstract][Full Text] [Related]
19. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
20. Antitumor response of CD14+/CD16+ monocyte subpopulation.
Szaflarska A; Baj-Krzyworzeka M; Siedlar M; Weglarczyk K; Ruggiero I; Hajto B; Zembala M
Exp Hematol; 2004 Aug; 32(8):748-55. PubMed ID: 15308326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
